Compendia Bioscience’s information solutions for oncology drug discovery allow scientists to harness the rapidly increasing volume of genome-scale molecular oncology data for therapeutic target and biomarker discovery, validation and prioritization. The biomedical research community is publishing such data at a staggering pace, however, the data is scattered in disparate formats, and impossible to analyze effectively without a unifying bioinformatics platform.

Compendia Bioscience’s flagship product, Oncomine™, integrates and unifies this data so that target expression across thousands of human tumors, hundreds of cancer types and subtypes, and millions of dollars of experiments can be assessed online in seconds. Oncomine enables users to discover and prioritize potential cancer targets and biomarkers, improving efficiency, strengthening product pipelines and increasing the likelihood of success.

Our mission
Harness the global collection of genomic data to change the practice of medicine

Our vision

• All the world’s genomic data can be made computable and provide a platform for sustainable competitive advantage
• We will design software that assists biologists and clinicians in discovering new insights from the world’s data
• Our software will dramatically reduce the time from question to answer — from hypothesis to result
• More rapid innovation will lead to treatment or practices that improve the quality of human life